Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Vincent Rajkumar
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Chemicals & Drugs
Physiology
Concepts & Ideas
Procedures
Anatomy
Sign-in to see full Profile
Network (preview)
96
Kyle, Robert
85
Greipp, Philip
80
Gertz, Morie
80
Dispenzieri, Angela
68
Lacy, Martha
63
Witzig, Thomas
61
Fonseca, Rafael
55
Lust, John
44
Kumar, Shaji
31
Therneau, Terry
30
Hayman, Suzanne
21
Litzow, Mark
21
Larson, Dirk
18
Zeldenrust, Steven
18
Melton, Joseph
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Vincent Rajkumar (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Gertz Morie A; Abonour Rafat; Heffner Leonard T; Greipp Philip R; Uno Hajime; Rajkumar S V
Clinical value of minor responses after 4 doses of rituximab in Waldenström macroglobulinaemia: a follow-up of the Eastern Cooperative Oncology Group E3A98 trial.
British journal of haematology 2009;147(5):677-80.
-
2009: Gössl Mario; Herrmann Jörg; Tang Hui; Versari Daniele; Galili Offer; Mannheim Dallit; Rajkumar S Vincent; Lerman Lilach O; Lerman Amir
Prevention of vasa vasorum neovascularization attenuates early neointima formation in experimental hypercholesterolemia.
Basic research in cardiology 2009;104(6):695-706.
-
2009: Lacy Martha Q; Jacobus Susanna; Blood Emily A; Kay Neil E; Rajkumar S Vincent; Greipp Philip R
Phase II study of interleukin-12 for treatment of plateau phase multiple myeloma (E1A96): a trial of the Eastern Cooperative Oncology Group.
Leukemia research 2009;33(11):1485-9.
-
2009: Lacy Martha Q; Hayman Suzanne R; Gertz Morie A; Dispenzieri Angela; Buadi Francis; Kumar Shaji; Greipp Philip R; Lust John A; Russell Stephen J; Dingli David; Kyle Robert A; Fonseca Rafael; Bergsagel P Leif; Roy Vivek; Mikhael Joseph R; Stewart A Keith; Laumann Kristina; Allred Jacob B; Mandrekar Sumithra J; Rajkumar S Vincent
Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(30):5008-14.
-
2009: Gertz Morie A; Leung Nelson; Lacy Martha Q; Dispenzieri Angela; Zeldenrust Steven R; Hayman Suzanne R; Buadi Francis K; Dingli David; Greipp Philip R; Kumar Shaji K; Lust John A; Rajkumar S Vincent; Russell Stephen J; Witzig Thomas E
Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009;24(10):3132-7.
-
2009: Rajkumar S Vincent
Prevention of progression in monoclonal gammopathy of undetermined significance.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(18):5606-8.
-
2009: Chee Cheng E; Kumar Shaji; Larson Dirk R; Kyle Robert A; Dispenzieri Angela; Gertz Morie A; Colby Colin L; Rajkumar S Vincent
The importance of bone marrow examination in determining complete response to therapy in patients with multiple myeloma.
Blood 2009;114(13):2617-8.
-
2009: Kyle Robert A; Rajkumar S Vincent
Treatment of multiple myeloma: a comprehensive review.
Clinical lymphoma & myeloma 2009;9(4):278-88.
-
2009: Bida John P; Kyle Robert A; Therneau Terry M; Melton L Joseph; Plevak Matthew F; Larson Dirk R; Dispenzieri Angela; Katzmann Jerry A; Rajkumar S Vincent
Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients.
Mayo Clinic proceedings. Mayo Clinic 2009;84(8):685-93.
-
2009: McJoynt Terre A; Hirzallah Muhanad A; Satele Daniel V; Pitzen Jason H; Alberts Steven R; Rajkumar S Vincent
Building a protocol expressway: the case of Mayo Clinic Cancer Center.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(23):3855-60.
-
2009: Kumar Shaji; Giralt Sergio; Stadtmauer Edward A; Harousseau Jean L; Palumbo Antonio; Bensinger William; Comenzo Raymond L; Lentzsch Suzanne; Munshi Nikhil; Niesvizky Ruben; San Miguel Jesus; Ludwig Heinz; Bergsagel Leif; Blade Joan; Lonial Sagar; Anderson Kenneth C; Tosi Patrizia; Sonneveld Pieter; Sezer Orhan; Vesole David; Cavo Michele; Einsele Hermann; Richardson Paul G; Durie Brian G M; Rajkumar S Vincent;
Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens.
Blood 2009;114(9):1729-35.
-
2009: Katzmann Jerry A; Kyle Robert A; Benson Joanne; Larson Dirk R; Snyder Melissa R; Lust John A; Rajkumar S Vincent; Dispenzieri Angela
Screening panels for detection of monoclonal gammopathies.
Clinical chemistry 2009;55(8):1517-22.
-
2009: Ng Alvin C; Kumar Shaji K; Rajkumar S Vincent; Drake Matthew T
Impact of vitamin D deficiency on the clinical presentation and prognosis of patients with newly diagnosed multiple myeloma.
American journal of hematology 2009;84(7):397-400.
-
2009: Kapoor Prashant; Kumar Shaji; Fonseca Rafael; Lacy Martha Q; Witzig Thomas E; Hayman Suzanne R; Dispenzieri Angela; Buadi Francis; Bergsagel P Leif; Gertz Morie A; Dalton Robert J; Mikhael Joseph R; Dingli David; Reeder Craig B; Lust John A; Russell Stephen J; Roy Vivek; Zeldenrust Steven R; Stewart A Keith; Kyle Robert A; Greipp Philip R; Rajkumar S Vincent
Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone.
Blood 2009;114(3):518-21.
-
2009: Vachon Celine M; Kyle Robert A; Therneau Terry M; Foreman Barbara J; Larson Dirk R; Colby Colin L; Phelps Tara K; Dispenzieri Angela; Kumar Shaji K; Katzmann Jerry A; Rajkumar S Vincent
Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance.
Blood 2009;114(4):785-90.
-
2009: Landgren Ola; Kyle Robert A; Hoppin Jane A; Beane Freeman Laura E; Cerhan James R; Katzmann Jerry A; Rajkumar S Vincent; Alavanja Michael C
Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the Agricultural Health Study.
Blood 2009;113(25):6386-91.
-
2009: Kyle Robert A; Jacobus Susanna; Friedenberg William R; Slabber Coenraad Frederik; Rajkumar S Vincent; Greipp Philip R
The treatment of multiple myeloma using vincristine, carmustine, melphalan, cyclophosphamide, and prednisone (VBMCP) alternating with high-dose cyclophosphamide and alpha(2)beta interferon versus VBMCP: results of a phase III Eastern Cooperative Oncology Group Study E5A93.
Cancer 2009;115(10):2155-64.
-
2009: Landgren Ola; Kyle Robert A; Pfeiffer Ruth M; Katzmann Jerry A; Caporaso Neil E; Hayes Richard B; Dispenzieri Angela; Kumar Shaji; Clark Raynell J; Baris Dalsu; Hoover Robert; Rajkumar S Vincent
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study.
Blood 2009;113(22):5412-7.
-
2009: Ng A C; Kumar S K; Russell S J; Rajkumar S V; Drake M T
Dexamethasone and the risk for adrenal suppression in multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(5):1009-11.
-
2009: Dingli David; Rajkumar S Vincent
Emerging therapies for multiple myeloma.
Oncology (Williston Park, N.Y.) 2009;23(5):407-15.
-
2009: Rajkumar S Vincent; Sonneveld Pieter
Front-line treatment in younger patients with multiple myeloma.
Seminars in hematology 2009;46(2):118-26.
-
2009: Braggio Esteban; Keats Jonathan J; Leleu Xavier; Van Wier Scott; Jimenez-Zepeda Victor H; Valdez Riccardo; Schop Roelandt F J; Price-Troska Tammy; Henderson Kimberly; Sacco Antonio; Azab Feda; Greipp Philip; Gertz Morie; Hayman Suzanne; Rajkumar S Vincent; Carpten John; Chesi Marta; Barrett Michael; Stewart A Keith; Dogan Ahmet; Bergsagel P Leif; Ghobrial Irene M; Fonseca Rafael
Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom's macroglobulinemia.
Cancer research 2009;69(8):3579-88.
-
2009: Kyle Robert A; Benson Joanne; Larson Dirk; Therneau Terry; Dispenzieri Angela; Melton Iii L Joseph; Rajkumar S Vincent
IgM monoclonal gammopathy of undetermined significance and smoldering Waldenström's macroglobulinemia.
Clinical lymphoma & myeloma 2009;9(1):17-8.
-
2009: Bryce Alan H; Ketterling Rhett P; Gertz Morie A; Lacy Martha; Knudson Ryan A; Zeldenrust Steven; Kumar Shaji; Hayman Suzanne; Buadi Francis; Kyle Robert A; Greipp Philip R; Lust John A; Russell Stephen; Rajkumar S Vincent; Fonseca Rafael; Dispenzieri Angela
Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis.
Haematologica 2009;94(3):380-6.
-
2009: Lust John A; Lacy Martha Q; Zeldenrust Steven R; Dispenzieri Angela; Gertz Morie A; Witzig Thomas E; Kumar Shaji; Hayman Suzanne R; Russell Stephen J; Buadi Francis K; Geyer Susan M; Campbell Megan E; Kyle Robert A; Rajkumar S Vincent; Greipp Philip R; Kline Michael P; Xiong Yuning; Moon-Tasson Laurie L; Donovan Kathleen A
Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component.
Mayo Clinic proceedings. Mayo Clinic 2009;84(2):114-22.
-
2009: Rajkumar S Vincent
Multiple myeloma.
Current problems in cancer 2009;33(1):7-64.
-
2009: Drake Matthew T; Rajkumar S Vincent
Effects of bortezomib on bone disease in multiple myeloma.
American journal of hematology 2009;84(1):1-2.
-
2009: Kyle R A; Rajkumar S V
Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(1):3-9.
-
2009: Ashrani Aneel A; Rajkumar S Vincent
Chemotherapy-associated thrombosis.
Cancer treatment and research 2009;148():181-206.
-
2008: Johnson David C; Corthals Sophie; Ramos Christine; Hoering Antje; Cocks Kim; Dickens Nicholas J; Haessler Jeff; Goldschmidt Harmut; Child J Anthony; Bell Sue E; Jackson Graham; Baris Dalsu; Rajkumar S Vincent; Davies Faith E; Durie Brian G M; Crowley John; Sonneveld Pieter; Van Ness Brian; Morgan Gareth J
Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping.
Blood 2008;112(13):4924-34.
-
2008: Wang Michael; Dimopoulos Meletios A; Chen Christine; Cibeira M Teresa; Attal Michel; Spencer Andrew; Rajkumar S Vincent; Yu Zhinuan; Olesnyckyj Marta; Zeldis Jerome B; Knight Robert D; Weber Donna M
Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposure.
Blood 2008;112(12):4445-51.
-
2008: Fonseca Rafael; Rajkumar S Vincent
Consolidation therapy with bortezomib/lenalidomide/ dexamethasone versus bortezomib/dexamethasone after a dexamethasone-based induction regimen in patients with multiple myeloma: a randomized phase III trial.
Clinical lymphoma & myeloma 2008;8(5):315-7.
-
2008: Rajkumar S Vincent
Treatment of myeloma: cure vs control.
Mayo Clinic proceedings. Mayo Clinic 2008;83(10):1142-5.
-
2008: Lonial Sagar; Richardson Paul G; San Miguel Jesús; Sonneveld Pieter; Schuster Michael W; Bladé Joan; Cavenagh Jamie; Rajkumar S Vincent; Jakubowiak Andrzej J; Esseltine Dixie-Lee; Anderson Kenneth C; Harousseau Jean-Luc
Characterisation of haematological profiles and low risk of thromboembolic events with bortezomib in patients with relapsed multiple myeloma.
British journal of haematology 2008;143(2):222-9.
-
2008: Snozek C L H; Katzmann J A; Kyle R A; Dispenzieri A; Larson D R; Therneau T M; Melton L J; Kumar S; Greipp P R; Clark R J; Rajkumar S V
Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging system.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(10):1933-7.
-
2008: Kumar Shaji; Rajkumar S Vincent
Many facets of bortezomib resistance/susceptibility.
Blood 2008;112(6):2177-8.
-
2008: Niesvizky Ruben; Richardson Paul G; Rajkumar S Vincent; Coleman Morton; Rosiñol Laura; Sonneveld Pieter; Schuster Michael W; Irwin David; Stadtmauer Edward A; Facon Thierry; Harousseau Jean-Luc; Boral Anthony L; Esseltine Dixie-Lee; Anderson Kenneth C; Bladé Joan
The relationship between quality of response and clinical benefit for patients treated on the bortezomib arm of the international, randomized, phase 3 APEX trial in relapsed multiple myeloma.
British journal of haematology 2008;143(1):46-53.
-
2008: Kumar S; Mahmood S T; Lacy M Q; Dispenzieri A; Hayman S R; Buadi F K; Dingli D; Rajkumar S V; Litzow M R; Gertz M A
Impact of early relapse after auto-SCT for multiple myeloma.
Bone marrow transplantation 2008;42(6):413-20.
-
2008: Kapoor Prashant; Snozek Christine L H; Colby Colin; Larson Dirk R; Katzmann Jerry A; Rajkumar S Vincent; Greipp Philip R
Clinical impact of discordance in serum albumin measurements on myeloma international staging system.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(24):4051-2.
-
2008: Lacy Martha Q; Dispenzieri Angela; Hayman Suzanne R; Kumar Shaji; Kyle Robert A; Rajkumar S Vincent; Edwards Brooks S; Rodeheffer Richard J; Frantz Robert P; Kushwaha Sudhir S; Clavell Alfredo L; Dearani Joseph A; Sundt Thoralf M; Daly Richard C; McGregor Christopher G A; Gastineau Dennis A; Litzow Mark R; Gertz Morie A
Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2008;27(8):823-9.
-
2008: Kumar Shaji K; Dingli David; Lacy Martha Q; Dispenzieri Angela; Hayman Suzanne R; Buadi Francis K; Rajkumar S Vincent; Litzow Mark R; Gertz Morie A
Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysis.
American journal of hematology 2008;83(8):614-7.
-
2008: Rajkumar S Vincent; Durie Brian G M
Eliminating the complete response penalty from myeloma response criteria.
Blood 2008;111(12):5759-60.
-
2008: Kumar S K; Dingli D; Dispenzieri A; Lacy M Q; Hayman S R; Buadi F K; Rajkumar S V; Litzow M R; Gertz M A
Impact of pretransplant therapy in patients with newly diagnosed myeloma undergoing autologous SCT.
Bone marrow transplantation 2008;41(12):1013-9.
-
2008: Rajkumar S Vincent; Rosiñol Laura; Hussein Mohamad; Catalano John; Jedrzejczak Wieslaw; Lucy Lela; Olesnyckyj Marta; Yu Zhinuan; Knight Robert; Zeldis Jerome B; Bladé Joan
Multicenter, randomized, double-blind, placebo-controlled study of thalidomide plus dexamethasone compared with dexamethasone as initial therapy for newly diagnosed multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(13):2171-7.
-
2008: Kline Michael P; Rajkumar S Vincent; Timm Michael M; Kimlinger Teresa K; Haug Jessica L; Lust John A; Greipp Philip R; Kumar Shaji
R-(-)-gossypol (AT-101) activates programmed cell death in multiple myeloma cells.
Experimental hematology 2008;36(5):568-76.
-
2008: Tiedemann R E; Gonzalez-Paz N; Kyle R A; Santana-Davila R; Price-Troska T; Van Wier S A; Chng W J; Ketterling R P; Gertz M A; Henderson K; Greipp P R; Dispenzieri A; Lacy M Q; Rajkumar S V; Bergsagel P L; Stewart A K; Fonseca R
Genetic aberrations and survival in plasma cell leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(5):1044-52.
-
2008: Kapoor Prashant; Greipp Patricia T; Morice William G; Rajkumar S Vincent; Witzig Thomas E; Greipp Philip R
Anti-CD20 monoclonal antibody therapy in multiple myeloma.
British journal of haematology 2008;141(2):135-48.
-
2008: Kumar Shaji K; Dingli David; Lacy Martha Q; Dispenzieri Angela; Hayman Suzanne R; Buadi Francis K; Rajkumar S Vincent; Litzow Mark R; Gertz Morie A
Outcome after autologous stem cell transplantation for multiple myeloma in patients with preceding plasma cell disorders.
British journal of haematology 2008;141(2):205-11.
-
2008: Menon Smitha Patiyil; Rajkumar S Vincent; Lacy Martha; Falco Patrizia; Palumbo Antonio
Thromboembolic events with lenalidomide-based therapy for multiple myeloma.
Cancer 2008;112(7):1522-8.
-
2008: Kyle Robert A; Rajkumar S Vincent
Multiple myeloma.
Blood 2008;111(6):2962-72.
-
2008: Kumar Shaji; Dispenzieri Angela; Lacy Martha Q; Hayman Suzanne R; Leung Nelson; Zeldenrust Steve R; Buadi Francis K; Kyle Robert A; Rajkumar S Vincent; Gertz Morie A
Serum uric acid: novel prognostic factor in primary systemic amyloidosis.
Mayo Clinic proceedings. Mayo Clinic 2008;83(3):297-303.
-
2008: Kumar Shaji K; Rajkumar S Vincent; Dispenzieri Angela; Lacy Martha Q; Hayman Suzanne R; Buadi Francis K; Zeldenrust Steven R; Dingli David; Russell Stephen J; Lust John A; Greipp Philip R; Kyle Robert A; Gertz Morie A
Improved survival in multiple myeloma and the impact of novel therapies.
Blood 2008;111(5):2516-20.
-
2008: Rajkumar S Vincent
Controversies regarding the use of dexamethasone in patients with multiple myeloma.
Clinical advances in hematology & oncology : H&O 2008;6(2):103, 141.
-
2008: Anderson K C; Kyle R A; Rajkumar S V; Stewart A K; Weber D; Richardson P;
Clinically relevant end points and new drug approvals for myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(2):231-9.
-
2008: Dispenzieri Angela; Kyle Robert A; Katzmann Jerry A; Therneau Terry M; Larson Dirk; Benson Joanne; Clark Raynell J; Melton L Joseph; Gertz Morie A; Kumar Shaji K; Fonseca Rafael; Jelinek Diane F; Rajkumar S Vincent
Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma.
Blood 2008;111(2):785-9.
-
2007: Rajkumar S Vincent; Buadi Francis
Multiple myeloma: new staging systems for diagnosis, prognosis and response evaluation.
Best practice & research. Clinical haematology 2007;20(4):665-80.
-
2007: Kyle Robert A; Rajkumar S Vincent
Epidemiology of the plasma-cell disorders.
Best practice & research. Clinical haematology 2007;20(4):637-64.
-
2007: Landgren Ola; Katzmann Jerry A; Hsing Ann W; Pfeiffer Ruth M; Kyle Robert A; Yeboah Edward D; Biritwum Richard B; Tettey Yao; Adjei Andrew A; Larson Dirk R; Dispenzieri Angela; Melton L Joseph; Goldin Lynn R; McMaster Mary L; Caporaso Neil E; Rajkumar S Vincent
Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana.
Mayo Clinic proceedings. Mayo Clinic 2007;82(12):1468-73.
-
2007: Kyle Robert A; Rajkumar S Vincent
Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression.
British journal of haematology 2007;139(5):730-43.
-
2007: Rajkumar S Vincent; Palumbo Antonio
Management of newly diagnosed myeloma.
Hematology/oncology clinics of North America 2007;21(6):1141-56, ix-x.
-
2007: Kyle Robert A; Rajkumar S Vincent
Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Hematology/oncology clinics of North America 2007;21(6):1093-113, ix.
-
2007: Weber Donna M; Chen Christine; Niesvizky Ruben; Wang Michael; Belch Andrew; Stadtmauer Edward A; Siegel David; Borrello Ivan; Rajkumar S Vincent; Chanan-Khan Asher Alban; Lonial Sagar; Yu Zhinuan; Patin John; Olesnyckyj Marta; Zeldis Jerome B; Knight Robert D;
Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America.
The New England journal of medicine 2007;357(21):2133-42.
-
2007: Richardson Paul G; Sonneveld Pieter; Schuster Michael; Irwin David; Stadtmauer Edward; Facon Thierry; Harousseau Jean-Luc; Ben-Yehuda Dina; Lonial Sagar; Goldschmidt Hartmut; Reece Donna; Miguel Jesus San; Bladé Joan; Boccadoro Mario; Cavenagh Jamie; Alsina Melissa; Rajkumar S Vincent; Lacy Martha; Jakubowiak Andrzej; Dalton William; Boral Anthony; Esseltine Dixie-Lee; Schenkein David; Anderson Kenneth C
Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial.
Blood 2007;110(10):3557-60.
-
2007: Rajkumar S Vincent; Richardson Paul G; Lacy Martha Q; Dispenzieri Angela; Greipp Philip R; Witzig Thomas E; Schlossman Robert; Sidor Carolyn F; Anderson Kenneth C; Gertz Morie A
Novel therapy with 2-methoxyestradiol for the treatment of relapsed and plateau phase multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(20):6162-7.
-
2007: Lacy Martha Q; Gertz Morie A; Dispenzieri Angela; Hayman Suzanne R; Geyer Susan; Kabat Brian; Zeldenrust Steven R; Kumar Shaji; Greipp Philip R; Fonseca Rafael; Lust John A; Russell Stephen J; Kyle Robert A; Witzig Thomas E; Bergsagel P Leif; Stewart A Keith; Rajkumar S Vincent
Long-term results of response to therapy, time to progression, and survival with lenalidomide plus dexamethasone in newly diagnosed myeloma.
Mayo Clinic proceedings. Mayo Clinic 2007;82(10):1179-84.
-
2007: Kumar S; Dispenzieri A; Lacy M Q; Hayman S R; Buadi F K; Gastineau D A; Litzow M R; Fonseca R; Roy V; Rajkumar S V; Gertz M A
Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(9):2035-42.
-
2007: Rajkumar S Vincent; Lacy Martha Q; Kyle Robert A
Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Blood reviews 2007;21(5):255-65.
-
2007: Leung Nelson; Rajkumar S Vincent
Renal manifestations of plasma cell disorders.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2007;50(1):155-65.
-
2007: Kline M P; Rajkumar S V; Timm M M; Kimlinger T K; Haug J L; Lust J A; Greipp P R; Kumar S
ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cells.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(7):1549-60.
-
2007: Rajkumar S Vincent; Kyle Robert A
Allografting or autografting for myeloma.
The New England journal of medicine 2007;356(25):2646-8; author reply 2646-8.
-
2007: Kyle Robert A; Remstein Ellen D; Therneau Terry M; Dispenzieri Angela; Kurtin Paul J; Hodnefield Janice M; Larson Dirk R; Plevak Matthew F; Jelinek Diane F; Fonseca Rafael; Melton Lee Joseph; Rajkumar S Vincent
Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma.
The New England journal of medicine 2007;356(25):2582-90.
-
2007: Rajkumar S Vincent; Gertz Morie A
Advances in the treatment of amyloidosis.
The New England journal of medicine 2007;356(23):2413-5.
-
2007: Snozek Christine L H; Saenger Amy K; Greipp Philip R; Bryant Sandra C; Kyle Robert A; Rajkumar S Vincent; Katzmann Jerry A
Comparison of bromcresol green and agarose protein electrophoresis for quantitation of serum albumin in multiple myeloma.
Clinical chemistry 2007;53(6):1099-103.
-
2007: Kline Michael; Donovan Kathleen; Wellik Linda; Lust Christopher; Jin Wendy; Moon-Tasson Laurie; Xiong Yuning; Witzig Thomas E; Kumar Shaji; Rajkumar S Vincent; Lust John A
Cytokine and chemokine profiles in multiple myeloma; significance of stromal interaction and correlation of IL-8 production with disease progression.
Leukemia research 2007;31(5):591-8.
-
2007: Chng Wee J; Kumar Shaji; Vanwier Scott; Ahmann Greg; Price-Troska Tammy; Henderson Kim; Chung Tae-Hoon; Kim Seungchan; Mulligan George; Bryant Barbara; Carpten John; Gertz Morie; Rajkumar S Vincent; Lacy Martha; Dispenzieri Angela; Kyle Robert; Greipp Philip; Bergsagel P Leif; Fonseca Rafael
Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling.
Cancer research 2007;67(7):2982-9.
-
2007: Dispenzieri Angela; Rajkumar S Vincent; Gertz Morie A; Fonseca Rafael; Lacy Martha Q; Bergsagel P Leif; Kyle Robert A; Greipp Philip R; Witzig Thomas E; Reeder Craig B; Lust John A; Russell Stephen J; Hayman Suzanne R; Roy Vivek; Kumar Shaji; Zeldenrust Steven R; Dalton Robert J; Stewart A Keith
Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-adapted Therapy (mSMART): consensus statement.
Mayo Clinic proceedings. Mayo Clinic 2007;82(3):323-41.
-
2007: Ashrani Aneel A; Rajkumar S Vincent
Chronic kidney disease, anemia, and epoetin.
The New England journal of medicine 2007;356(9):957-8; author reply 958-9.
-
2007: Stewart A K; Bergsagel P L; Greipp P R; Dispenzieri A; Gertz M A; Hayman S R; Kumar S; Lacy M Q; Lust J A; Russell S J; Witzig T E; Zeldenrust S R; Dingli D; Reeder C B; Roy V; Kyle R A; Rajkumar S V; Fonseca R
A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(3):529-34.
-
2007: Chng W J; Price-Troska T; Gonzalez-Paz N; Van Wier S; Jacobus S; Blood E; Henderson K; Oken M; Van Ness B; Greipp P; Rajkumar S V; Fonseca R
Clinical significance of TP53 mutation in myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(3):582-4.
-
2007: Adjei Alex A; Rajkumar S Vincent; Tefferi Ayalew
Cancer symposium for the practitioner: introduction to solid tumors.
Mayo Clinic proceedings. Mayo Clinic 2007;82(1):107-9.
-
2007: Dispenzieri Angela; Lacy Martha Q; Zeldenrust Steven R; Hayman Suzanne R; Kumar Shaji K; Geyer Susan M; Lust John A; Allred Jacob B; Witzig Thomas E; Rajkumar S Vincent; Greipp Philip R; Russell Stephen J; Kabat Brian; Gertz Morie A
The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis.
Blood 2007;109(2):465-70.
-
2006: Katzmann Jerry A; Dispenzieri Angela; Kyle Robert A; Snyder Melissa R; Plevak Matthew F; Larson Dirk R; Abraham Roshini S; Lust John A; Melton L Joseph; Rajkumar S Vincent
Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays.
Mayo Clinic proceedings. Mayo Clinic 2006;81(12):1575-8.
-
2006: Fonseca R; Van Wier S A; Chng W J; Ketterling R; Lacy M Q; Dispenzieri A; Bergsagel P L; Rajkumar S V; Greipp P R; Litzow M R; Price-Troska T; Henderson K J; Ahmann G J; Gertz M A
Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(11):2034-40.
-
2006: Richardson Paul G; Blood Emily; Mitsiades Constantine S; Jagannath Sundar; Zeldenrust Steven R; Alsina Melissa; Schlossman Robert L; Rajkumar S Vincent; Desikan K Raman; Hideshima Teru; Munshi Nikhil C; Kelly-Colson Kathleen; Doss Deborah; McKenney Mary L; Gorelik Svetlana; Warren Diane; Freeman Andrea; Rich Rebecca; Wu Anfang; Olesnyckyj Marta; Wride Kenton; Dalton William S; Zeldis Jerome; Knight Robert; Weller Edie; Anderson Kenneth C
A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma.
Blood 2006;108(10):3458-64.
-
2006: Sviggum Hans P; Davis Mark D P; Rajkumar S Vincent; Dispenzieri Angela
Dermatologic adverse effects of lenalidomide therapy for amyloidosis and multiple myeloma.
Archives of dermatology 2006;142(10):1298-302.
-
2006: Timm M M; Kimlinger T K; Haug J L; Kline M P; Greipp P R; Rajkumar S V; Kumar S K
Thymoglobulin targets multiple plasma cell antigens and has in vitro and in vivo activity in multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(10):1863-9.
-
2006: Bryce Alan H; Dispenzieri Angela; Kyle Robert A; Lacy Martha Q; Rajkumar S Vincent; Inwards David J; Yasenchak Christopher A; Kumar Shaji K; Gertz Morie A
Response to rituximab in patients with type II cryoglobulinemia.
Clinical lymphoma & myeloma 2006;7(2):140-4.
-
2006: Schop Roelandt F J; Van Wier Scott A; Xu Ruifang; Ghobrial Irene; Ahmann Gregory J; Greipp Philip R; Kyle Robert A; Dispenzieri Angela; Lacy Martha Q; Rajkumar S Vincent; Gertz Morie A; Fonseca Rafael
6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance.
Cancer genetics and cytogenetics 2006;169(2):150-3.
-
2006: Kyle Robert A; Rajkumar S Vincent
Monoclonal gammopathy of undetermined significance.
British journal of haematology 2006;134(6):573-89.
-
2006: Dingli David; Kyle Robert A; Rajkumar S Vincent; Nowakowski Grzegorz S; Larson Dirk R; Bida John P; Gertz Morie A; Therneau Terry M; Melton L Joseph; Dispenzieri Angela; Katzmann Jerry A
Immunoglobulin free light chains and solitary plasmacytoma of bone.
Blood 2006;108(6):1979-83.
-
2006: Kademani Deepak; Koka Sreenivas; Lacy Martha Q; Rajkumar S Vincent
Primary surgical therapy for osteonecrosis of the jaw secondary to bisphosphonate therapy.
Mayo Clinic proceedings. Mayo Clinic 2006;81(8):1100-3.
-
2006: Lacy Martha Q; Dispenzieri Angela; Gertz Morie A; Greipp Philip R; Gollbach Kimberly L; Hayman Suzanne R; Kumar Shaji; Lust John A; Rajkumar S Vincent; Russell Stephen J; Witzig Thomas E; Zeldenrust Steven R; Dingli David; Bergsagel P Lief; Fonseca Rafael; Reeder Craig B; Stewart A Keith; Roy Vivek; Dalton Robert J; Carr Alan B; Kademani Deepak; Keller Eugene E; Viozzi Christopher F; Kyle Robert A
Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma.
Mayo Clinic proceedings. Mayo Clinic 2006;81(8):1047-53.
-
2006: Kimlinger Teresa; Kline Michael; Kumar Shaji; Lust John; Witzig Thomas; Rajkumar S Vincent
Differential expression of vascular endothelial growth factors and their receptors in multiple myeloma.
Haematologica 2006;91(8):1033-40.
-
2006: Richardson Paul G; Briemberg Hannah; Jagannath Sundar; Wen Patrick Y; Barlogie Bart; Berenson James; Singhal Seema; Siegel David S; Irwin David; Schuster Michael; Srkalovic Gordan; Alexanian Raymond; Rajkumar S Vincent; Limentani Steven; Alsina Melissa; Orlowski Robert Z; Najarian Kevin; Esseltine Dixie; Anderson Kenneth C; Amato Anthony A
Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(19):3113-20.
-
2006: Kumar Shaji; Rajkumar S Vincent
Thalidomide and lenalidomide in the treatment of multiple myeloma.
European journal of cancer (Oxford, England : 1990) 2006;42(11):1612-22.
-
2006: Rajkumar S Vincent; Dispenzieri Angela; Kyle Robert A
Monoclonal gammopathy of undetermined significance, Waldenström macroglobulinemia, AL amyloidosis, and related plasma cell disorders: diagnosis and treatment.
Mayo Clinic proceedings. Mayo Clinic 2006;81(5):693-703.
-
2006: Rajkumar S Vincent; Blood Emily
Lenalidomide and venous thrombosis in multiple myeloma.
The New England journal of medicine 2006;354(19):2079-80.
-
2006: Chng Wee J; Ahmann Greg J; Henderson Kim; Santana-Davila Rafael; Greipp Philip R; Gertz Morie A; Lacy Martha Q; Dispenzieri Angela; Kumar Shaji; Rajkumar S Vincent; Lust John A; Kyle Robert A; Zeldenrust Steven R; Hayman Suzanne R; Fonseca Rafael
Clinical implication of centrosome amplification in plasma cell neoplasm.
Blood 2006;107(9):3669-75.
-
2006: Dispenzieri Angela; Lacy Martha Q; Katzmann Jerry A; Rajkumar S Vincent; Abraham Roshini S; Hayman Suzanne R; Kumar Shaji K; Clark Raynell; Kyle Robert A; Litzow Mark R; Inwards David J; Ansell Stephen M; Micallef Ivana M; Porrata Luis F; Elliott Michelle A; Johnston Patrick B; Greipp Philip R; Witzig Thomas E; Zeldenrust Steven R; Russell Stephen J; Gastineau Dennis; Gertz Morie A
Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation.
Blood 2006;107(8):3378-83.
-
2006: Dingli David; Nowakowski Grzegorz S; Dispenzieri Angela; Lacy Martha Q; Hayman Suzanne R; Rajkumar S Vincent; Greipp Philip R; Litzow Mark R; Gastineau Dennis A; Witzig Thomas E; Gertz Morie A
Flow cytometric detection of circulating myeloma cells before transplantation in patients with multiple myeloma: a simple risk stratification system.
Blood 2006;107(8):3384-8.
-
2006: Kyle Robert A; Therneau Terry M; Rajkumar S Vincent; Larson Dirk R; Plevak Matthew F; Offord Janice R; Dispenzieri Angela; Katzmann Jerry A; Melton L Joseph
Prevalence of monoclonal gammopathy of undetermined significance.
The New England journal of medicine 2006;354(13):1362-9.
-
2006: Richardson Paul G; Barlogie Bart; Berenson James; Singhal Seema; Jagannath Sundar; Irwin David H; Rajkumar S Vincent; Srkalovic Gordan; Alsina Melissa; Anderson Kenneth C
Extended follow-up of a phase II trial in relapsed, refractory multiple myeloma:: final time-to-event results from the SUMMIT trial.
Cancer 2006;106(6):1316-9.
-
2006: Rajkumar S Vincent; Blood Emily; Vesole David; Fonseca Rafael; Greipp Philip R;
Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(3):431-6.
-
2006: Dispenzieri Angela; Gertz Morie A; Lacy Martha Q; Geyer Susan M; Greipp Phillip R; Rajkumar S Vincent; Kimlinger Teresa; Lust John A; Fonseca Rafael; Allred Jacob; Witzig Thomas E
A phase II trial of imatinib in patients with refractory/relapsed myeloma.
Leukemia & lymphoma 2006;47(1):39-42.
-
2005: Rajkumar S Vincent
Thalidomide therapy and deep venous thrombosis in multiple myeloma.
Mayo Clinic proceedings. Mayo Clinic 2005;80(12):1549-51.
-
2005: Dingli David; Rajkumar S Vincent; Nowakowski Grzegorz S; Gertz Morie A; Dispenzieri Angela; Lacy Martha Q; Hayman Suzanne; Fonseca Rafael; Lust John A; Kyle Robert A; Greipp Philip R; Witzig Thomas E
Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trial.
Haematologica 2005;90(12):1650-4.
-
2005: Rajkumar S Vincent; Hayman Suzanne R; Lacy Martha Q; Dispenzieri Angela; Geyer Susan M; Kabat Brian; Zeldenrust Steven R; Kumar Shaji; Greipp Philip R; Fonseca Rafael; Lust John A; Russell Stephen J; Kyle Robert A; Witzig Thomas E; Gertz Morie A
Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma.
Blood 2005;106(13):4050-3.
-
2005: Lane Steven W; Gill Devinder; Mollee Peter N; Rajkumar S Vincent
Role of VAD in the initial treatment of multiple myeloma.
Blood 2005;106(10):3674; author reply 3674-5.
-
2005: Berenson James R; Jagannath Sundar; Barlogie Bart; Siegel David T; Alexanian Raymond; Richardson Paul G; Irwin David; Alsina Melissa; Rajkumar S Vincent; Srkalovic Gordon; Singhal Seema; Limentani Steven; Niesvizky Ruben; Esseltine Dixie L; Trehu Elizabeth; Schenkein David P; Anderson Kenneth
Safety of prolonged therapy with bortezomib in relapsed or refractory multiple myeloma.
Cancer 2005;104(10):2141-8.
-
2005: Richardson Paul Gerard Guy; Barlogie Bart; Berenson James; Singhal Seema; Jagannath Sundar; Irwin David; Rajkumar S Vincent; Hideshima Teru; Xiao Hugh; Esseltine Dixie; Schenkein David; Anderson Kenneth C;
Clinical factors predictive of outcome with bortezomib in patients with relapsed, refractory multiple myeloma.
Blood 2005;106(9):2977-81.
-
2005: Lacy Martha Q; Hogan William J; Gertz Morie A; Dispenzieri Angela; Rajkumar S Vincent; Hayman Suzanne; Kumar Shaji; Litzow Mark R; Schroeter Arnold L
Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantation.
Archives of dermatology 2005;141(10):1277-82.
-
2005: Kumar Shaji; Rajkumar S Vincent
Thalidomide and dexamethasone: therapy for multiple myeloma.
Expert review of anticancer therapy 2005;5(5):759-66.
-
2005: Rajkumar S Vincent; Dispenzieri Angela
Evaluation and monitoring of response to therapy in multiple myeloma.
Haematologica 2005;90(10):1305-8.
-
2005: Rajkumar S Vincent; Kyle Robert A
Multiple myeloma: diagnosis and treatment.
Mayo Clinic proceedings. Mayo Clinic 2005;80(10):1371-82.
-
2005: Nowakowski Grzegorz S; Witzig Thomas E; Dingli David; Tracz Michal J; Gertz Morie A; Lacy Martha Q; Lust John A; Dispenzieri Angela; Greipp Philip R; Kyle Robert A; Rajkumar S Vincent
Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma.
Blood 2005;106(7):2276-9.
-
2005: Kyle Robert A; Rajkumar S Vincent
Monoclonal gammopathy of undetermined significance.
Clinical lymphoma & myeloma 2005;6(2):102-14.
-
2005: Kumar Shaji; Rajkumar S Vincent; Kyle Robert A; Lacy Martha Q; Dispenzieri Angela; Fonseca Rafael; Lust John A; Gertz Morie A; Greipp Philip R; Witzig Thomas E
Prognostic value of circulating plasma cells in monoclonal gammopathy of undetermined significance.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5668-74.
-
2005: Tefferi Ayalew; Rajkumar S Vincent; Adjei Alex A
Introduction to a cancer symposium for the practitioner.
Mayo Clinic proceedings. Mayo Clinic 2005;80(8):1085-6.
-
2005: Kumar S; Rajkumar S V; Kimlinger T; Greipp P R; Witzig T E
CD45 expression by bone marrow plasma cells in multiple myeloma: clinical and biological correlations.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(8):1466-70.
-
2005: Rajkumar S Vincent; Kyle Robert A; Therneau Terry M; Melton L Joseph; Bradwell Arthur R; Clark Raynell J; Larson Dirk R; Plevak Matthew F; Dispenzieri Angela; Katzmann Jerry A
Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance.
Blood 2005;106(3):812-7.
-
2005: Rajkumar S Vincent
Novel approaches to the management of myeloma.
Oncology (Williston Park, N.Y.) 2005;19(5):621-5.
-
2005: Kyle Robert A; Rajkumar S Vincent; Therneau Terry M; Larson Dirk R; Plevak Matthew F; Melton L Joseph
Prognostic factors and predictors of outcome of immunoglobulin M monoclonal gammopathy of undetermined significance.
Clinical lymphoma 2005;5(4):257-60.
-
2005: Melton L Joseph; Kyle Robert A; Achenbach Sara J; Oberg Ann L; Rajkumar S Vincent
Fracture risk with multiple myeloma: a population-based study.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2005;20(3):487-93.
-
2005: Rajkumar S Vincent; Richardson Paul G; Hideshima Teru; Anderson Kenneth C
Proteasome inhibition as a novel therapeutic target in human cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(3):630-9.
-
2005: Dispenzieri A; Wiseman G A; Lacy M Q; Litzow M R; Anderson P M; Gastineau D A; Tefferi A; Inwards D J; Micallef I N M; Ansell S M; Porrata L; Elliott M A; Lust J A; Greipp P R; Rajkumar S V; Fonseca R; Witzig T E; Erlichman C; Sloan J A; Gertz M A
A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(1):118-25.
-
2005: Rajkumar S Vincent
MGUS and smoldering multiple myeloma: update on pathogenesis, natural history, and management.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2005;():340-5.
-
2005: Kyle Robert A; Rajkumar S Vincent
Monoclonal gammopathies of undetermined significance.
Best practice & research. Clinical haematology 2005;18(4):689-707.
-
2005: Rajkumar S Vincent; Kyle Robert A
Conventional therapy and approach to management.
Best practice & research. Clinical haematology 2005;18(4):585-601.
-
2004: Kyle Robert A; Therneau Terry M; Rajkumar S Vincent; Larson Dirk R; Plevak Matthew F; Melton L Joseph
Incidence of multiple myeloma in Olmsted County, Minnesota: Trend over 6 decades.
Cancer 2004;101(11):2667-74.
-
2004: Rajkumar S Vincent; Kyle Robert A; Therneau Terry M; Clark Raynell J; Bradwell Arthur R; Melton L Joseph; Larson Dirk R; Plevak Matthew F; Katzmann Jerry A
Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance.
British journal of haematology 2004;127(3):308-10.
-
2004: Kyle Robert A; Rajkumar S Vincent
Multiple myeloma.
The New England journal of medicine 2004;351(18):1860-73.
-
2004: Dispenzieri Angela; Gertz Morie A; Kyle Robert A; Lacy Martha Q; Burritt Mary F; Therneau Terry M; Greipp Philip R; Witzig Thomas E; Lust John A; Rajkumar S Vincent; Fonseca Rafael; Zeldenrust Steven R; McGregor Christopher G A; Jaffe Allan S
Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(18):3751-7.
-
2004: Kumar Shaji; Rajkumar S Vincent; Greipp Philip R; Witzig Thomas E
Cell proliferation of myeloma plasma cells: comparison of the blood and marrow compartments.
American journal of hematology 2004;77(1):7-11.
-
2004: Kumar S; Lacy M Q; Dispenzieri A; Rajkumar S V; Fonseca R; Geyer S; Allmer C; Witzig T E; Lust J A; Greipp P R; Kyle R A; Litzow M R; Gertz M A
Single agent dexamethasone for pre-stem cell transplant induction therapy for multiple myeloma.
Bone marrow transplantation 2004;34(6):485-90.
-
2004: Dispenzieri Angela; Gertz Morie A; Kyle Robert A; Lacy Martha Q; Burritt Mary F; Therneau Terry M; McConnell Joseph P; Litzow Mark R; Gastineau Dennis A; Tefferi Ayalew; Inwards David J; Micallef Ivana N; Ansell Stephen M; Porrata Luis F; Elliott Michelle A; Hogan William J; Rajkumar S Vincent; Fonseca Rafael; Greipp Philip R; Witzig Thomas E; Lust John A; Zeldenrust Steven R; Snow Denise S; Hayman Susan R; McGregor Christopher G A; Jaffe Allan S
Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation.
Blood 2004;104(6):1881-7.
-
2004: Kumar S; Gertz M A; Dispenzieri A; Lacy M Q; Wellik L A; Fonseca R; Lust J A; Witzig T E; Kyle R A; Greipp P R; Rajkumar S V
Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy.
Bone marrow transplantation 2004;34(3):235-9.
-
2004: Kumar Shaji; Witzig Thomas E; Timm Michael; Haug Jessica; Wellik Linda; Kimlinger Teresa K; Greipp Philip R; Rajkumar S Vincent
Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression.
Blood 2004;104(4):1159-65.
-
2004: Rajkumar S Vincent
Thalidomide: tragic past and promising future.
Mayo Clinic proceedings. Mayo Clinic 2004;79(7):899-903.
-
2004: Kumar Shaji K; Therneau Terry M; Gertz Morie A; Lacy Martha Q; Dispenzieri Angela; Rajkumar S Vincent; Fonseca Rafael; Witzig Thomas E; Lust John A; Larson Dirk R; Kyle Robert A; Greipp Philip R
Clinical course of patients with relapsed multiple myeloma.
Mayo Clinic proceedings. Mayo Clinic 2004;79(7):867-74.
-
2004: Kyle Robert A; Therneau Terry M; Rajkumar S Vincent; Larson Dirk R; Plevak Matthew F; Melton L Joseph
Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later.
Mayo Clinic proceedings. Mayo Clinic 2004;79(7):859-66.
-
2004: Kumar S; Lacy M Q; Dispenzieri A; Rajkumar S V; Fonseca R; Geyer S; Allmer C; Witzig T E; Lust J A; Greipp P R; Kyle R A; Litzow M R; Gertz M A
High-dose therapy and autologous stem cell transplantation for multiple myeloma poorly responsive to initial therapy.
Bone marrow transplantation 2004;34(2):161-7.
-
2004: Ma Cynthia X; Lacy Martha Q; Rompala John F; Dispenzieri Angela; Rajkumar S Vincent; Greipp Philip R; Fonseca Rafael; Kyle Robert A; Gertz Morie A
Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma.
Blood 2004;104(1):40-2.
-
2004: Kumar Shaji; Witzig Thomas E; Rajkumar S Vincent
Thalidomid: current role in the treatment of non-plasma cell malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(12):2477-88.
-
2004: Thompson Michael A; Kyle Robert A; Melton L Joseph; Plevak Matthew F; Rajkumar S Vincent
Effect of statins, smoking and obesity on progression of monoclonal gammopathy of undetermined significance: a case-control study.
Haematologica 2004;89(5):626-8.
-
2004: Dispenzieri Angela; Kyle Robert A; Lacy Martha Q; Therneau Terry M; Larson Dirk R; Plevak Matthew F; Rajkumar S Vincent; Fonseca Rafael; Greipp Philip R; Witzig Thomas E; Lust John A; Zeldenrust Steven R; Snow Denise S; Hayman Susan R; Litzow Mark R; Gastineau Dennis A; Tefferi Ayalew; Inwards David J; Micallef Ivana N; Ansell Stephen M; Porrata Luis F; Elliott Michelle A; Gertz Morie A
Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study.
Blood 2004;103(10):3960-3.
-
2004: Kumar S; Witzig T E; Dispenzieri A; Lacy M Q; Wellik L E; Fonseca R; Lust J A; Gertz M A; Kyle R A; Greipp P R; Rajkumar S V
Effect of thalidomide therapy on bone marrow angiogenesis in multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(3):624-7.
-
2004: Munshi Nikhil C; Hideshima Teru; Carrasco Daniel; Shammas Masood; Auclair Daniel; Davies Faith; Mitsiades Nicholas; Mitsiades Constantine; Kim Ryung Suk; Li Cheng; Rajkumar S Vincent; Fonseca Rafael; Bergsagel Lief; Chauhan Dharminder; Anderson Kenneth C
Identification of genes modulated in multiple myeloma using genetically identical twin samples.
Blood 2004;103(5):1799-806.
-
2004: Melton L Joseph; Rajkumar S Vincent; Khosla Sundeep; Achenbach Sara J; Oberg Ann L; Kyle Robert A
Fracture risk in monoclonal gammopathy of undetermined significance.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2004;19(1):25-30.
-
2003: Dispenzieri Angela; Lacy Martha Q; Rajkumar S Vincent; Geyer Susan M; Witzig Thomas E; Fonseca Rafael; Lust John A; Greipp Philip R; Kyle Robert A; Gertz Morie A
Poor tolerance to high doses of thalidomide in patients with primary systemic amyloidosis.
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 2003;10(4):257-61.
-
2003: Kumar S; Litzow M R; Rajkumar S V
Effect of allogeneic stem cell transplantation on bone marrow angiogenesis in chronic myelogenous leukemia.
Bone marrow transplantation 2003;32(11):1065-9.
-
2003: Kyle Robert A; Therneau Terry M; Rajkumar S Vincent; Remstein Ellen D; Offord Janice R; Larson Dirk R; Plevak Matthew F; Melton L Joseph
Long-term follow-up of IgM monoclonal gammopathy of undetermined significance.
Blood 2003;102(10):3759-64.
-
2003: Rajkumar S Vincent
Thalidomide in newly diagnosed multiple myeloma and overview of experience in smoldering/indolent disease.
Seminars in hematology 2003;40(4 Suppl 4):17-22.
-
2003: Thompson Michael A; Witzig Thomas E; Kumar Shaji; Timm Michael M; Haug Jessica; Fonseca Rafael; Greipp Philip R; Lust John A; Rajkumar S Vincent
Plasma levels of tumour necrosis factor alpha and interleukin-6 predict progression-free survival following thalidomide therapy in patients with previously untreated multiple myeloma.
British journal of haematology 2003;123(2):305-8.
-
2003: Kumar S; Witzig T E; Timm M; Haug J; Wellik L; Fonseca R; Greipp P R; Rajkumar S V
Expression of VEGF and its receptors by myeloma cells.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(10):2025-31.
-
2003: Ghobrial Irene M; Rajkumar S Vincent
Management of thalidomide toxicity.
The journal of supportive oncology 2003;1(3):194-205.
-
2003: Pera Miguel; Nelson Heidi; Rajkumar S Vincent; Young-Fadok Tonia M; Burgart Lawrence J
Influence of postoperative acute-phase response on angiogenesis and tumor growth: open vs. laparoscopic-assisted surgery in mice.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2003;7(6):783-90.
-
2003: Ghobrial I M; Dispenzieri A; Bundy K L; Gastineau D A; Rajkumar S V; Therneau T M; Lacy M Q; Witzig T E; Litzow M R; Christensen B R; Hayman S; Pribula C G; Gertz M A
Effect of thalidomide on stem cell collection and engraftment in patients with multiple myeloma.
Bone marrow transplantation 2003;32(6):587-92.
-
2003: Kyle Robert A; Rajkumar S Vincent
Monoclonal gammopathies of undetermined significance: a review.
Immunological reviews 2003;194():112-39.
-
2003: Kumar Shaji; Witzig Thomas E; Greipp Philip R; Rajkumar S Vincent
Bone marrow angiogenesis and circulating plasma cells in multiple myeloma.
British journal of haematology 2003;122(2):272-4.
-
2003: Richardson Paul G; Barlogie Bart; Berenson James; Singhal Seema; Jagannath Sundar; Irwin David; Rajkumar S Vincent; Srkalovic Gordan; Alsina Melissa; Alexanian Raymond; Siegel David; Orlowski Robert Z; Kuter David; Limentani Steven A; Lee Stephanie; Hideshima Teru; Esseltine Dixie-Lee; Kauffman Michael; Adams Julian; Schenkein David P; Anderson Kenneth C
A phase 2 study of bortezomib in relapsed, refractory myeloma.
The New England journal of medicine 2003;348(26):2609-17.
-
2003: Loprinzi Charles; Rajkumar S Vincent
Why not start with thalidomide?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(11):2211-4.
-
2003: Rajkumar S Vincent; Hayman Suzanne; Greipp Philip R
Angiogenesis in Waldenstrom's macroglobulinemia.
Seminars in oncology 2003;30(2):262-4.
-
2003: Kyle R A; Therneau T M; Rajkumar S V; Offord J R; Larson D R; Plevak M F; Melton L J
Long-term follow-up of IgM monoclonal gammopathy of undetermined significance.
Seminars in oncology 2003;30(2):169-71.
-
2003: Rajkumar S V; Gertz M A; Lacy M Q; Dispenzieri A; Fonseca R; Geyer S M; Iturria N; Kumar S; Lust J A; Kyle R A; Greipp P R; Witzig T E
Thalidomide as initial therapy for early-stage myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(4):775-9.
-
2003: Hall Virginia C; El-Azhary Rokea A; Bouwhuis Saskia; Rajkumar S Vincent
Dermatologic side effects of thalidomide in patients with multiple myeloma.
Journal of the American Academy of Dermatology 2003;48(4):548-52.
-
2003: Dispenzieri Angela; Kyle Robert A; Lacy Martha Q; Rajkumar S Vincent; Therneau Terry M; Larson Dirk R; Greipp Philip R; Witzig Thomas E; Basu Rita; Suarez Guillermo A; Fonseca Rafael; Lust John A; Gertz Morie A
POEMS syndrome: definitions and long-term outcome.
Blood 2003;101(7):2496-506.
-
2003: Kumar Shaji; Fonseca Rafael; Dispenzieri Angela; Lacy Martha Q; Lust John A; Wellik Linda; Witzig Thomas E; Gertz Morie A; Kyle Robert A; Greipp Philip R; Rajkumar S Vincent
Prognostic value of angiogenesis in solitary bone plasmacytoma.
Blood 2003;101(5):1715-7.
-
2003: Molina Julian R; Rajkumar S Vincent
Bone marrow angiogenesis in multiple myeloma: closing in on the loop.
Haematologica 2003;88(2):122-4.
-
2003: Pardanani Animesh; Witzig Thomas E; Schroeder Georgene; McElroy Edwin A; Fonseca Rafael; Dispenzieri Angela; Lacy Martha Q; Lust John A; Kyle Robert A; Greipp Philip R; Gertz Morie A; Rajkumar S Vincent
Circulating peripheral blood plasma cells as a prognostic indicator in patients with primary systemic amyloidosis.
Blood 2003;101(3):827-30.
-
2003: Kumar Shaji; Gertz Morie A; Dispenzieri Angela; Lacy Martha Q; Geyer Susan M; Iturria Nancy L; Fonseca Rafael; Hayman Suzanne R; Lust John A; Kyle Robert A; Greipp Philip R; Witzig Thomas E; Rajkumar S Vincent
Response rate, durability of response, and survival after thalidomide therapy for relapsed multiple myeloma.
Mayo Clinic proceedings. Mayo Clinic 2003;78(1):34-9.
-
2003: Kyle Robert A; Gertz Morie A; Witzig Thomas E; Lust John A; Lacy Martha Q; Dispenzieri Angela; Fonseca Rafael; Rajkumar S Vincent; Offord Janice R; Larson Dirk R; Plevak Matthew E; Therneau Terry M; Greipp Philip R
Review of 1027 patients with newly diagnosed multiple myeloma.
Mayo Clinic proceedings. Mayo Clinic 2003;78(1):21-33.
-
2002: Rajkumar S Vincent; Kyle Robert A; Gertz Morie A
Myeloma and the newly diagnosed patient: a focus on treatment and management.
Seminars in oncology 2002;29(6 Suppl 17):5-10.
-
2002: Dingli David; Timm Michael; Russell Stephen J; Witzig Thomas E; Rajkumar S Vincent
Promising preclinical activity of 2-methoxyestradiol in multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(12):3948-54.
-
2002: Rajkumar S Vincent; Kyle Robert A; Plevak Matthew F; Murray Joseph A; Therneau Terry M
Helicobacter pylori infection and monoclonal gammopathy of undetermined significance.
British journal of haematology 2002;119(3):706-8.
-
2002: Kumar Shaji; Fonseca Rafael; Dispenzieri Angela; Lacy Martha Q; Lust John A; Witzig Thomas E; Gertz Morie A; Kyle Robert A; Greipp Philip R; Rajkumar S Vincent
Bone marrow angiogenesis in multiple myeloma: effect of therapy.
British journal of haematology 2002;119(3):665-71.
-
2002: Rajkumar S Vincent; Hayman Suzanne; Gertz Morie A; Dispenzieri Angela; Lacy Martha Q; Greipp Philip R; Geyer Susan; Iturria Nancy; Fonseca Rafael; Lust John A; Kyle Robert A; Witzig Thomas E
Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(21):4319-23.
-
2002: Kyle Robert A; Rajkumar S Vincent
Monoclonal gammopathies of undetermined significance.
Reviews in clinical and experimental hematology 2002;6(3):225-52.
-
2002: Riegert-Johnson Douglas L; Sandhu Nicole; Rajkumar S Vincent; Patel Robin
Thrombotic thrombocytopenic purpura associated with a hepatic abscess due to Actinomyces turicensis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;35(5):636-7.
-
2002: Rajkumar S Vincent; Gertz Morie A; Kyle Robert A; Greipp Philip R;
Current therapy for multiple myeloma.
Mayo Clinic proceedings. Mayo Clinic 2002;77(8):813-22.
-
2002: Fonseca Rafael; Bailey Richard J; Ahmann Gregory J; Rajkumar S Vincent; Hoyer James D; Lust John A; Kyle Robert A; Gertz Morie A; Greipp Philip R; Dewald Gordon W
Genomic abnormalities in monoclonal gammopathy of undetermined significance.
Blood 2002;100(4):1417-24.
-
2002: Rajkumar S Vincent; Mesa Ruben A; Fonseca Rafael; Schroeder Georgene; Plevak Matthew F; Dispenzieri Angela; Lacy Martha Q; Lust John A; Witzig Thomas E; Gertz Morie A; Kyle Robert A; Russell Stephen J; Greipp Philip R
Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(7):2210-6.
-
2002: Gertz Morie A; Rajkumar S Vincent
Primary systemic amyloidosis.
Current treatment options in oncology 2002;3(3):261-71.
-
2002: Mesa Ruben A; Hanson Curtis A; Li Chin-Yang; Yoon Soo-Young; Rajkumar S Vincent; Schroeder Georgene; Tefferi Ayalew
Diagnostic and prognostic value of bone marrow angiogenesis and megakaryocyte c-Mpl expression in essential thrombocythemia.
Blood 2002;99(11):4131-7.
-
2002: Kumar S; Witzig T E; Rajkumar S V
Thalidomide as an anti-cancer agent.
Journal of cellular and molecular medicine 2002;6(2):160-74.
-
2002: Kyle Robert A; Therneau Terry M; Rajkumar S Vincent; Offord Janice R; Larson Dirk R; Plevak Matthew F; Melton L Joseph
A long-term study of prognosis in monoclonal gammopathy of undetermined significance.
The New England journal of medicine 2002;346(8):564-9.
-
2002: Rajkumar S Vincent; Mesa Ruben A; Tefferi Ayalew
A review of angiogenesis and anti-angiogenic therapy in hematologic malignancies.
Journal of hematotherapy & stem cell research 2002;11(1):33-47.
-
2002: Fonseca Rafael; Harrington David; Oken Martin M; Dewald Gordon W; Bailey Richard J; Van Wier Scott A; Henderson Kimberly J; Blood Emily A; Rajkumar S Vincent; Kay Neil E; Van Ness Brian; Greipp Philip R
Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group study.
Cancer research 2002;62(3):715-20.
-
2002: Schop Roelandt F J; Jalal Syed M; Van Wier Scott A; Ahmann Gregory J; Bailey Richard J; Kyle Robert A; Greipp Philip R; Rajkumar S Vincent; Gertz Morie A; Lust John A; Lacy Martha Q; Dispenzieri Angela; Witzig Thomas E; Fonseca Rafael
Deletions of 17p13.1 and 13q14 are uncommon in Waldenström macroglobulinemia clonal cells and mostly seen at the time of disease progression.
Cancer genetics and cytogenetics 2002;132(1):55-60.
-
2001: Rajkumar S V; Fonseca R; Dispenzieri A; Lacy M Q; Lust J A; Witzig T E; Therneau T M; Kyle R A; Greipp P R; Gertz M A
Methods for estimation of bone marrow plasma cell involvement in myeloma: predictive value for response and survival in patients undergoing autologous stem cell transplantation.
American journal of hematology 2001;68(4):269-75.
-
2001: Kyle R A; Rajkumar S V
Therapeutic application of thalidomide in multiple myeloma.
Seminars in oncology 2001;28(6):583-7.
-
2001: Rajkumar S V; Kyle R A
Angiogenesis in multiple myeloma.
Seminars in oncology 2001;28(6):560-4.
-
2001: Hayman S R; Bailey R J; Jalal S M; Ahmann G J; Dispenzieri A; Gertz M A; Greipp P R; Kyle R A; Lacy M Q; Rajkumar S V; Witzig T E; Lust J A; Fonseca R
Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosis.
Blood 2001;98(7):2266-8.
-
2001: Rajkumar S V; Dispenzieri A; Fonseca R; Lacy M Q; Geyer S; Lust J A; Kyle R A; Greipp P R; Gertz M A; Witzig T E
Thalidomide for previously untreated indolent or smoldering multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(8):1274-6.
-
2001: Rajkumar S V
Current status of thalidomide in the treatment of cancer.
Oncology (Williston Park, N.Y.) 2001;15(7):867-74; discussion 877-9.
-
2001: Dispenzieri A; Lacy M Q; Kyle R A; Therneau T M; Larson D R; Rajkumar S V; Fonseca R; Greipp P R; Witzig T E; Lust J A; Gertz M A
Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(14):3350-6.
-
2001: Rajkumar S V
Thalidomide in the treatment of multiple myeloma.
Expert review of anticancer therapy 2001;1(1):20-8.
-
2001: Rajkumar S V; Greipp P R
Angiogenesis in multiple myeloma.
British journal of haematology 2001;113(3):565.
-
2000: Rajkumar S V; Fonseca R; Dispenzieri A; Lacy M Q; Witzig T E; Lust J A; Larson D; Therneau T M; Kyle R A; Litzow M R; Greipp P R; Gertz M A
Effect of complete response on outcome following autologous stem cell transplantation for myeloma.
Bone marrow transplantation 2000;26(9):979-83.
-
2000: Mesa R A; Hanson C A; Rajkumar S V; Schroeder G; Tefferi A
Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia.
Blood 2000;96(10):3374-80.
-
2000: Fonseca R; Rajkumar S V; Ahmann G J; Jalal S M; Hoyer J D; Gertz M A; Kyle R A; Greipp P R; Dewald G W
Fish demonstrates treatment-related chromosome damage in myeloid but not plasma cells in primary systemic amyloidosis.
Leukemia & lymphoma 2000;39(3-4):391-5.
-
2000: Rajkumar S V; Witzig T E
A review of angiogenesis and antiangiogenic therapy with thalidomide in multiple myeloma.
Cancer treatment reviews 2000;26(5):351-62.
-
2000: Rajkumar S V; Fonseca R; Dispenzieri A; Lacy M Q; Lust J A; Witzig T E; Kyle R A; Gertz M A; Greipp P R
Thalidomide in the treatment of relapsed multiple myeloma.
Mayo Clinic proceedings. Mayo Clinic 2000;75(9):897-901.
-
2000: Rajkumar S V; Leong T; Roche P C; Fonseca R; Dispenzieri A; Lacy M Q; Lust J A; Witzig T E; Kyle R A; Gertz M A; Greipp P R
Prognostic value of bone marrow angiogenesis in multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(8):3111-6.
-
1999: Rajkumar S V; Greipp P R
Prognostic factors in multiple myeloma.
Hematology/oncology clinics of North America 1999;13(6):1295-314, xi.
-
1999: Kyle R A; Rajkumar S V
Monoclonal gammopathies of undetermined significance.
Hematology/oncology clinics of North America 1999;13(6):1181-202.
-
1999: Fonseca R; Hoyer J D; Aguayo P; Jalal S M; Ahmann G J; Rajkumar S V; Witzig T E; Lacy M Q; Dispenzieri A; Gertz M A; Kyle R A; Greipp P R
Clinical significance of the translocation (11;14)(q13;q32) in multiple myeloma.
Leukemia & lymphoma 1999;35(5-6):599-605.
-
1999: Rajkumar S; Fonseca R; Lacy M; Witzig T; Lust J; Greipp P; Therneau T; Kyle R; Litzow M; Gertz M
Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.
Bone marrow transplantation 1999;24(5):497-503.
-
1999: Rajkumar S V; Fonseca R; Dewald G W; Therneau T M; Lacy M Q; Kyle R A; Greipp P R; Gertz M A
Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myeloma.
Cancer genetics and cytogenetics 1999;113(1):73-7.
-
1999: Rajkumar S V; Fonseca R; Lacy M Q; Witzig T E; Lust J A; Greipp P R; Therneau T M; Kyle R A; Litzow M R; Gertz M A
Autologous stem cell transplantation for relapsed and primary refractory myeloma.
Bone marrow transplantation 1999;23(12):1267-72.
-
1999: Rajkumar S V; Fonseca R; Lacy M Q; Witzig T E; Lust J A; Greipp P R; Therneau T M; Kyle R A; Litzow M R; Gertz M A
Beta2-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma.
Bone marrow transplantation 1999;23(12):1261-6.
-
1999: Rajkumar S V; Fonseca R; Lacy M Q; Witzig T E; Therneau T M; Kyle R A; Litzow M R; Gertz M A; Greipp P R
Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(5):1551-7.
-
1999: Rajkumar S V; Fonseca R; Witzig T E; Gertz M A; Greipp P R
Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1999;13(3):469-72.
-
1998: Fonseca R; Rajkumar S V; White W L; Tefferi A; Hoagland H C
Anemia after orchiectomy.
American journal of hematology 1998;59(3):230-3.
-
1998: Rajkumar S V; Gertz M A; Kyle R A
Primary systemic amyloidosis with delayed progression to multiple myeloma.
Cancer 1998;82(8):1501-5.
Sign-in to see more
